Skip Navigation LinksHome > February 2013 - Volume 39 - Issue 2 > Tranexamic Acid and Trauma: Current Status and Knowledge Ga...
doi: 10.1097/SHK.0b013e318280409a
Review Articles

Tranexamic Acid and Trauma: Current Status and Knowledge Gaps With Recommended Research Priorities

Pusateri, Anthony E.*; Weiskopf, Richard B.; Bebarta, Vikhyat; Butler, Frank§; Cestero, Ramon F.; Chaudry, Irshad H.; Deal, Virgil**; Dorlac, Warren C.††; Gerhardt, Robert T.‡‡; Given, Michael B.§§; Hansen, Dan R.; Hoots, W. Keith∥∥; Klein, Harvey G.¶¶; Macdonald, Victor W.***; Mattox, Kenneth L.†††; Michael, Rodney A.***; Mogford, Jon‡‡‡; Montcalm-Smith, Elizabeth A.§§§; Niemeyer, Debra M.; Prusaczyk, W. Keith∥∥∥; Rappold, Joseph F.¶¶¶; Rassmussen, Todd‡‡; Rentas, Francisco****; Ross, James; Thompson, Christopher††††; Tucker, Leo D.‡‡‡‡; and The US DoD Hemorrhage and Resuscitation Research and Development Steering Committee

Editor's Choice
Collapse Box


ABSTRACT: A recent large civilian randomized controlled trial on the use of tranexamic acid (TXA) for trauma reported important survival benefits. Subsequently, successful use of TXA for combat casualties in Afghanistan was also reported. As a result of these promising studies, there has been growing interest in the use of TXA for trauma. Potential adverse effects of TXA have also been reported. A US Department of Defense committee conducted a review and assessment of knowledge gaps and research requirements regarding the use of TXA for the treatment of casualties that have experienced traumatic hemorrhage. We present identified knowledge gaps and associated research priorities. We believe that important knowledge gaps exist and that a targeted, prioritized research effort will contribute to the refinement of practice guidelines over time.

©2013The Shock Society

Follow Us



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.